On November 2, 2018 Constellation Pharmaceuticals, Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, reported that the Company will present at two investor conferences in November (Press release, Constellation Pharmaceuticals, NOV 2, 2018, View Source [SID1234530619]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

November 15 – Jefferies London Healthcare Conference at the Waldorf Hilton in London at 4:00 p.m. GMT/11:00 a.m. EST
November 28 – Evercore ISI 2018 Healthcare Conference at the Boston Harbor Hotel in Boston, at 10:15 a.m. EST
A live audio webcast of the presentation and an archive for replay will be available for both conferences on the Investor Relations section of Constellation’s website at View Source The audio webcast replays will be available for 90 days following the live presentations.